环境暴露在心力衰竭风险和进展中的作用
Omar Hahad1,2, Sojin Wass3, Sanjay Rajagopalan4
1Department of Cardiology - Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Nature reviews. Cardiology
|January 25, 2026
概括
环境暴露显著影响心力衰竭 (HF) 风险和进展. 了解暴露组,包括污染和社会因素,是预防和公共卫生战略的关键.
科学领域:
- 心血管医学 心血管医学
- 环境健康 环境健康
- 公共卫生 公共卫生
背景情况:
- 环境暴露对心力衰竭 (HF) 发生率和进展起着至关重要的作用.
- 暴露体,包括污染,气候和城市因素,与遗传倾向和病理生理机制相互作用.
- 健康的社会决定因素加剧了环境风险,不成比例地影响弱势群体.
研究的目的:
- 探索环境暴露和心力衰竭之间的复杂相互作用.
- 突出暴露基对心血管健康和HF结局的影响.
- 确定研究缺口,并建议未来HF预防和干预的方向.
主要方法:
- 审查关于环境暴露和心力衰竭的现有文献.
- 分析各种污染物 (空气,噪音,光,有毒金属) 和气候因素对高频的影响.
- 考虑健康的社会决定因素和保护性环境因素 (绿地,可行性).
- 探索将环境压力因素与HF结果联系起来的表观遗传机制.
主要成果:
- 污染和极端温度等不利的环境因素会对HF结果产生负面影响.
- 绿色空间等积极的环境因素与降低HF风险和改善血管健康有关.
- 环境压力因素可以从生命早期通过表观遗传改变影响HF.
- 社会经济地位放大了环境风险,导致健康差距.
结论:
- 对暴露组的全面理解对于解决心力衰竭的多因素病因至关重要.
- 未来的研究应该整合环境,遗传和多组数据,以改善风险预测.
- 针对性的公共卫生干预措施解决生物和社会决定因素对于HF预防至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
3.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
01:27Heart Failure I: Introduction
776
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776
01:29Heart Failure II: Pathophysiology
837
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
01:22Heart Failure Drugs: Diuretics
893
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
893
01:30Heart Failure V: Medical Management
256
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
256
01:22Heart Failure VI: Adjunct Therapies
301
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
301